Objective:To study the level of bcr/abl fusion gene expression in the diagnosis,treatment and prognosis in chronic myelogenous leukemia(CML)and primary myelofibrosis(MF).

• 目的 探讨bcr/abl融合基因的表达水平在慢性粒细胞白血病(CML)和原发性骨髓纤维化(MF)患者的诊断、疗效及预后观察中的意义。